Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice (Q27853373)
Jump to navigation
Jump to search
scientific article
- Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, <i>Drosophila</i> and mice
Language | Label | Description | Also known as |
---|---|---|---|
English | Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice |
scientific article |
|
Statements
1 reference
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice (English)
1 reference
17 May 2016
0 references
7
0 references
20
0 references
29011-22
0 references
1 reference
1 reference
1 reference